About SynapDx
SynapDx is a company based in Southborough (United States) founded in 2010. It operates as a D2C, and B2C. SynapDx has raised $32.75 million across 5 funding rounds from investors including LabCorp, Flare Capital Partners and North Bridge Venture Partners. SynapDx offers products and services including Spectros 280 IU, Genotropin 36 IU, Semaglutide 5 mg, and Zptropin 160 IU. SynapDx operates in a competitive market with competitors including Linus Biotechnology, Lineagen, MARAbio, SensOmics and Pediatric Bioscience, among others.
- Headquarter Southborough, United States
-
Sectors
HealthcareConsumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thesah
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.75 M (USD)
in 5 rounds
-
Latest Funding Round
$15.4 M (USD), Series C
Jul 24, 2013
-
Investors
LabCorp
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SynapDx
SynapDx offers a comprehensive portfolio of products and services, including Spectros 280 IU, Genotropin 36 IU, Semaglutide 5 mg, and Zptropin 160 IU. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides growth hormone for energy and muscle enhancement.
Supports hormone therapy for recovery and performance.
Assists in fat reduction and metabolic health improvement.
Offers hormone for anti-aging and vitality benefits.
Funding Insights of SynapDx
SynapDx has successfully raised a total of $32.75M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $15.4 million completed in July 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $15.4M
-
First Round
First Round
(02 Jun 2010)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2013 | Amount | Series C - SynapDx | Valuation | Google Ventures | |
| Mar, 2013 | Amount | Series C - SynapDx | Valuation |
investors |
|
| Feb, 2013 | Amount | Series C - SynapDx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SynapDx
SynapDx has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Flare Capital Partners and North Bridge Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
US focused seed to growth stage VC firm
|
Founded Year | Domain | Location | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SynapDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SynapDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synapdx Comparisons
Competitors of SynapDx
SynapDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Linus Biotechnology, Lineagen, MARAbio, SensOmics and Pediatric Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic tests for central nervous system and gastrointestinal disorders
|
|
| domain | founded_year | HQ Location |
Sequencing-based diagnostic tests and services for autism are provided.
|
|
| domain | founded_year | HQ Location |
A blood test for maternal autoantibody-related autism is developed.
|
|
| domain | founded_year | HQ Location |
Precision medicine for children's health is provided through genomic integration.
|
|
| domain | founded_year | HQ Location |
Provides blood biomarker-based diagnostics for autism spectrum disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synapdx
Frequently Asked Questions about SynapDx
When was SynapDx founded?
SynapDx was founded in 2010.
Where is SynapDx located?
SynapDx is headquartered in Southborough, United States. It is registered at Southborough, Massachusetts, United States.
Is SynapDx a funded company?
SynapDx is a funded company, having raised a total of $32.75M across 5 funding rounds to date. The company's 1st funding round was a Series C of $2M, raised on Jun 02, 2010.
What does SynapDx do?
SynapDX operates as an online retailer specializing in human growth hormone (HGH) products, including injections and pens, to enhance energy, muscle growth, and recovery. It provides lab-tested items with fast delivery options, targeting adults focused on fitness and anti-aging. The platform emphasizes safe purchasing, verified brands, and customer support, while advising medical consultation for use.
Who are the top competitors of SynapDx?
SynapDx's top competitors include Linus Biotechnology, MARAbio and Lineagen.
What products or services does SynapDx offer?
SynapDx offers Spectros 280 IU, Genotropin 36 IU, Semaglutide 5 mg, and Zptropin 160 IU.
Who are SynapDx's investors?
SynapDx has 7 investors. Key investors include LabCorp, Flare Capital Partners, North Bridge Venture Partners, General Catalyst, and Google Ventures.